http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5324511-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_066828a4b6f7a816447cb8ba1bcbb40e
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-1214
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-21
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-104
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
filingDate 1989-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1994-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_56636ae11e8f37d4fe55a4b830064834
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a864b6a825de199288c649f9efdbac6e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_70ea23da23616034046c70fe5f218b27
publicationDate 1994-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-5324511-A
titleOfInvention Vaccines and immunoglobulin G-containing preparations active against pseudomonas aeruginosa
abstract Vaccines that are active against Pseudomonas aeruginosa infections contain a single flagellar (H) antigen of serotype a or a combination of a single flagellar (H) antigen of serotype a with a flagellar (H) antigen of serotype b. Applied to man, the vaccines according to the invention induce the formation of antibodies that are directed against any combination of partial flagellar (H) antigens a0, a1, a2, a3, a4 and b, inhibiting the motility of Pseudomonas aeruginosa pathogens and inducing the killing of the pathogens by phagocytizing cells of the human immune system.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5897852-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5502039-A
priorityDate 1988-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4946677-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4831121-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393946
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127796639
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399383
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226398707
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136050722
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399382
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID791
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395986
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3423265
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395985
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6306
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6106
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53782688
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9554281
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2907
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID232
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID994
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID857
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399946
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394420
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24749
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399947
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394438
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6140
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396360

Total number of triples: 53.